Psyence Biomedical Ltd.
PBM
$3.48
-$0.08-2.25%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 0.00% | 4.12% | 16.54% | 0.00% | 0.00% |
| Total Receivables | 0.00% | 108.27% | -- | -- | 0.00% |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 0.00% | 386.59% | -- | -- | 0.00% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 0.00% | 0.00% | -- | -- | 0.00% |
| Total Current Assets | 0.00% | 19.41% | -- | -- | 0.00% |
|
|
|||||
| Total Current Assets | 0.00% | 19.41% | -- | -- | 0.00% |
| Net Property, Plant & Equipment | 0.00% | -29.89% | -- | -- | 0.00% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 0.00% | -- | -- | -- | -- |
| Total Assets | 0.00% | 37.14% | -- | -- | 0.00% |
|
|
|||||
| Total Accounts Payable | 0.00% | -2.71% | -- | -- | 0.00% |
| Total Accrued Expenses | 0.00% | -19.26% | -- | -- | 0.00% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Liabilities | 0.00% | -48.70% | -- | -- | 0.00% |
| Total Other Current Liabilities | 0.00% | -48.70% | -- | -- | 0.00% |
| Total Current Liabilities | 0.00% | -33.92% | -- | -- | 0.00% |
|
|
|||||
| Total Current Liabilities | 0.00% | -33.92% | -- | -- | 0.00% |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | 0.00% | -33.92% | -- | -- | 0.00% |
|
|
|||||
| Common Stock & APIC | 0.00% | 14.32% | -- | -- | 0.00% |
| Retained Earnings | 0.00% | -8.46% | -- | -- | 0.00% |
| Treasury Stock & Other | 0.00% | 11.07% | -- | -- | 0.00% |
| Total Common Equity | 0.00% | 42.78% | 76.54% | 0.00% | 0.00% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 0.00% | 42.78% | 76.54% | 0.00% | 0.00% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 0.00% | 42.78% | 76.54% | 0.00% | 0.00% |
|
|
|||||